Analysis of the Association Between CFH Y402H Polymorphism and Response to Intravitreal Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (nAMD). Biomol Biomed 2018, 18 (3), 260-267. https://doi.org/10.17305/bjbms.2018.2493.